Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
VNDA | F | Vanda Pharmaceuticals Inc. | -1.74 | |
FBIO | F | Fortress Biotech, Inc. | 0.00 | |
GH | F | Guardant Health, Inc. | -0.71 | |
EQ | F | Equillium, Inc. | 0.01 | |
BBIO | F | BridgeBio Pharma, Inc. | -1.32 | |
CLDX | F | Celldex Therapeutics, Inc. | 0.83 | |
NXTC | F | NextCure, Inc. | 0.00 | |
VTGN | F | VistaGen Therapeutics, Inc. | -0.33 | |
CYTK | F | Cytokinetics, Incorporated | 0.25 | |
FGEN | F | FibroGen, Inc | 0.03 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Related Stock Lists:
Biopharmaceutical
Medicine
Biotechnology
Cancer
Clinical Medicine
Disease
Immune System
Immunology
Immunotherapy
Monoclonal Antibody
Cancer Treatment
Depressive Disorder
Major Depressive Disorder
Oncology
Ovarian Cancer
Solid Tumors
Treatment Of Major Depressive Disorder
Abdominal Pain
Achondroplasia
Acute Myeloid Leukemia
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
EIRL | D | iShares MSCI Ireland Capped ETF | 20.21 | |
PINK | D | Simplify Health Care ETF | 12.84 | |
PCIG | C | Polen Capital International Growth ETF | 11.4 | |
HELX | D | Franklin Genomic Advancements ETF | 9.58 | |
BBH | D | Market Vectors Biotech ETF | 8.5 |
Compare ETFs
Related Industries:
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Information Technology Services
Medical Devices
Related Stock Lists:
Biotechnology
Biopharmaceutical
Life Sciences
Biology
Medicine
Biomarkers
Cancer
Clinical Research
Clinical Trial
Contract Research Organization
Contract Research Organizations
Diabetes
Drug Discovery
Monoclonal Antibodies
Schizophrenia
Adenosine
Alcohol
Anemia
Antipsychotic
Antisense RNA
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Popular Now
Recent Comments
- LillyMilly1 on LILM
- LillyMilly1 on LILM
- TraderMike on RYDE what a RIDE!!! Holy Crap!
- Crunching_The_Market on RYDE what a RIDE!!! Holy Crap!
- LillyMilly1 on LILM
From the Blog
Featured Articles